Life sciences briefing: Friday, Sept. 21, 2007
Featured companies: CG Therapeutics, Complete Genomics, ConforMIS, Flexible Medical Systems, LeMaitre Vascular, MAP Pharmaceuticals, ParaPro, Vascular Architects, Zars Pharma
(UPDATED on 10/1/07: See below.)
[NOTE: Posting has been slow recently for personal reasons. I'll be doing my best to catch up today.]
Complete Genomics raises funding for high-speed sequencing — Complete Genomics, a Mountain View, Calif., developer of high-speed genome sequencing technology, said it raised an undisclosed sum in a second funding round, VentureWire reports (subscription required). The company said… Continue Reading
Helicos BioSciences lowers IPO price, raises $48.6M, then sags further
Helicos BioSciences, a Cambridge, Mass., maker of high-speed genome-sequencing equipment, raised $48.6 million in an IPO, well under the $81 million it had hoped to raise. My earlier item on the Helicos IPO is here.
Helicos is the latest biotechnology company to find itself at the mercy of unforgiving IPO investors. The company cut its estimated per-share offering range to $10 to $11 from its earlier estimate of $13 to $15, then found itself forced to… Continue Reading
DNA sequencer Helicos BioSciences aims to raise $81M in IPO
Helicos BioSciences, a Cambridge, Mass., developer of high-speed DNA and RNA sequencing technology, hopes to raise as much as $81 million in an initial offering, according to an SEC filing.
The company said in the filing that it hopes to offer 5.4 million shares at $13 to $15 per share. The IPO market for biotechs has been tepid recently, and several companies have recently either lowered their asking price or withdrawn their proposed offering altogether.
Helicos’ technology… Continue Reading